This clinical trial is focused on understanding the effects of a medication called Glycostigmin, which is a solution for injection containing two active substances: glycopyrronium bromide and neostigmine methylsulfate. The study is particularly interested in how these substances work together to reverse muscle relaxation during general anesthesia. Muscle relaxation is often used during surgeries to help keep the body still, and reversing this relaxation is important for recovery after the procedure.

The main purpose of the study is to find out how often muscle relaxation returns after it has been reversed with neostigmine. This is important because sometimes, even after the medication is given to reverse the muscle relaxation, the muscles might not fully regain their normal function right away. The study will monitor patients who are undergoing general anesthesia to see how their muscles respond after receiving the reversal medication.

Participants in the study will receive the medication through an intravenous infusion, which means it will be delivered directly into the bloodstream. The study will observe the effects of the medication over a short period to gather information on how well it works in preventing the reappearance of muscle relaxation. This research aims to improve the safety and effectiveness of reversing muscle relaxation during surgeries.